HEADER TRANSCRIPTION 23-MAR-20 7BQ0 TITLE X-RAY STRUCTURE OF HUMAN PPARALPHA LIGAND BINDING DOMAIN-FENOFIBRIC TITLE 2 ACID-SRC1 COACTIVATOR PEPTIDE CO-CRYSTALS OBTAINED BY DELIPIDATION TITLE 3 AND CO-CRYSTALLIZATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 15-MERIC PEPTIDE FROM NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 7 CHAIN: B, D; COMPND 8 EC: 2.3.1.48; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMATA,R.ISHIKAWA,M.AKAHANE,T.OYAMA,I.ISHII REVDAT 3 29-NOV-23 7BQ0 1 REMARK REVDAT 2 02-DEC-20 7BQ0 1 JRNL REVDAT 1 11-NOV-20 7BQ0 0 JRNL AUTH S.KAMATA,T.OYAMA,K.SAITO,A.HONDA,Y.YAMAMOTO,K.SUDA, JRNL AUTH 2 R.ISHIKAWA,T.ITOH,Y.WATANABE,T.SHIBATA,K.UCHIDA,M.SUEMATSU, JRNL AUTH 3 I.ISHII JRNL TITL PPAR ALPHA LIGAND-BINDING DOMAIN STRUCTURES WITH ENDOGENOUS JRNL TITL 2 FATTY ACIDS AND FIBRATES. JRNL REF ISCIENCE V. 23 01727 2020 JRNL REFN ESSN 2589-0042 JRNL PMID 33205029 JRNL DOI 10.1016/J.ISCI.2020.101727 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1-2575-000 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.74 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.920 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 70307 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 3210 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.7390 - 5.4980 0.98 4322 223 0.1589 0.1962 REMARK 3 2 5.4980 - 4.3659 0.98 4344 220 0.1478 0.1661 REMARK 3 3 4.3659 - 3.8145 0.92 4069 239 0.1458 0.1640 REMARK 3 4 3.8145 - 3.4660 0.96 4234 229 0.1807 0.2070 REMARK 3 5 3.4660 - 3.2177 0.96 4273 222 0.2064 0.2511 REMARK 3 6 3.2177 - 3.0281 0.97 4219 239 0.2106 0.2166 REMARK 3 7 3.0281 - 2.8765 0.97 4236 231 0.2163 0.2371 REMARK 3 8 2.8765 - 2.7513 0.97 4303 223 0.2062 0.2248 REMARK 3 9 2.7513 - 2.6454 0.97 4334 182 0.2071 0.2084 REMARK 3 10 2.6454 - 2.5542 0.97 4362 152 0.1990 0.2076 REMARK 3 11 2.5542 - 2.4743 0.97 4268 203 0.2035 0.2152 REMARK 3 12 2.4743 - 2.4036 0.96 4255 242 0.2011 0.2428 REMARK 3 13 2.4036 - 2.3403 0.96 4202 237 0.1999 0.2499 REMARK 3 14 2.3403 - 2.2832 0.95 4218 239 0.2045 0.2405 REMARK 3 15 2.2832 - 2.2313 0.94 4180 210 0.2089 0.2407 REMARK 3 16 2.2313 - 2.1838 0.92 4007 241 0.2004 0.2159 REMARK 3 17 2.1838 - 2.1402 0.94 4108 248 0.2047 0.2631 REMARK 3 18 2.1402 - 2.0998 0.95 4226 146 0.2085 0.2595 REMARK 3 19 2.0998 - 2.0623 0.95 4239 206 0.2077 0.2478 REMARK 3 20 2.0623 - 2.0273 0.95 4222 182 0.2061 0.2443 REMARK 3 21 2.0273 - 1.9946 0.95 4220 195 0.2208 0.2813 REMARK 3 22 1.9946 - 1.9639 0.95 4216 225 0.2165 0.2618 REMARK 3 23 1.9639 - 1.9351 0.95 4132 192 0.2241 0.2516 REMARK 3 24 1.9351 - 1.9078 0.95 4197 241 0.2219 0.2664 REMARK 3 25 1.9078 - 1.8820 0.94 4154 262 0.2285 0.2718 REMARK 3 26 1.8820 - 1.8576 0.95 4214 162 0.2352 0.2515 REMARK 3 27 1.8576 - 1.8344 0.95 4149 231 0.2406 0.2948 REMARK 3 28 1.8344 - 1.8123 0.95 4246 201 0.2341 0.3043 REMARK 3 29 1.8123 - 1.7912 0.94 4196 192 0.2292 0.2617 REMARK 3 30 1.7912 - 1.7711 0.92 4072 208 0.2535 0.3386 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 4728 REMARK 3 ANGLE : 1.259 6389 REMARK 3 CHIRALITY : 0.077 720 REMARK 3 PLANARITY : 0.008 818 REMARK 3 DIHEDRAL : 11.843 2867 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7BQ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1300016265. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70340 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 47.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.02600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.33800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.16 REMARK 200 STARTING MODEL: 3SP6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS (PH 8.5), 25 %(W/V) PEG3350, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.30900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 196 REMARK 465 SER A 197 REMARK 465 HIS A 198 REMARK 465 LEU B 683 REMARK 465 GLY B 697 REMARK 465 GLY C 196 REMARK 465 SER C 197 REMARK 465 LEU D 683 REMARK 465 GLY D 697 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 232 CG CD CE NZ REMARK 470 LYS C 232 CG CD CE NZ REMARK 470 GLU D 685 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 226 NE - CZ - NH1 ANGL. DEV. = 5.2 DEGREES REMARK 500 ARG A 226 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG C 226 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG C 226 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS C 384 49.13 -92.98 REMARK 500 ASN C 393 70.50 -100.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5A A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5A A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5A C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5A C 502 DBREF 7BQ0 A 200 468 UNP Q07869 PPARA_HUMAN 200 468 DBREF 7BQ0 B 683 697 UNP Q15788 NCOA1_HUMAN 683 697 DBREF 7BQ0 C 200 468 UNP Q07869 PPARA_HUMAN 200 468 DBREF 7BQ0 D 683 697 UNP Q15788 NCOA1_HUMAN 683 697 SEQADV 7BQ0 GLY A 196 UNP Q07869 EXPRESSION TAG SEQADV 7BQ0 SER A 197 UNP Q07869 EXPRESSION TAG SEQADV 7BQ0 HIS A 198 UNP Q07869 EXPRESSION TAG SEQADV 7BQ0 MET A 199 UNP Q07869 EXPRESSION TAG SEQADV 7BQ0 GLY C 196 UNP Q07869 EXPRESSION TAG SEQADV 7BQ0 SER C 197 UNP Q07869 EXPRESSION TAG SEQADV 7BQ0 HIS C 198 UNP Q07869 EXPRESSION TAG SEQADV 7BQ0 MET C 199 UNP Q07869 EXPRESSION TAG SEQRES 1 A 273 GLY SER HIS MET THR ALA ASP LEU LYS SER LEU ALA LYS SEQRES 2 A 273 ARG ILE TYR GLU ALA TYR LEU LYS ASN PHE ASN MET ASN SEQRES 3 A 273 LYS VAL LYS ALA ARG VAL ILE LEU SER GLY LYS ALA SER SEQRES 4 A 273 ASN ASN PRO PRO PHE VAL ILE HIS ASP MET GLU THR LEU SEQRES 5 A 273 CYS MET ALA GLU LYS THR LEU VAL ALA LYS LEU VAL ALA SEQRES 6 A 273 ASN GLY ILE GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE SEQRES 7 A 273 HIS CYS CYS GLN CYS THR SER VAL GLU THR VAL THR GLU SEQRES 8 A 273 LEU THR GLU PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN SEQRES 9 A 273 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 A 273 VAL TYR GLU ALA ILE PHE ALA MET LEU SER SER VAL MET SEQRES 11 A 273 ASN LYS ASP GLY MET LEU VAL ALA TYR GLY ASN GLY PHE SEQRES 12 A 273 ILE THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 13 A 273 CYS ASP ILE MET GLU PRO LYS PHE ASP PHE ALA MET LYS SEQRES 14 A 273 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP ILE SER LEU SEQRES 15 A 273 PHE VAL ALA ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY SEQRES 16 A 273 LEU LEU ASN VAL GLY HIS ILE GLU LYS MET GLN GLU GLY SEQRES 17 A 273 ILE VAL HIS VAL LEU ARG LEU HIS LEU GLN SER ASN HIS SEQRES 18 A 273 PRO ASP ASP ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 A 273 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 A 273 LEU VAL GLN ILE ILE LYS LYS THR GLU SER ASP ALA ALA SEQRES 21 A 273 LEU HIS PRO LEU LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 B 15 LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN SEQRES 2 B 15 GLU GLY SEQRES 1 C 273 GLY SER HIS MET THR ALA ASP LEU LYS SER LEU ALA LYS SEQRES 2 C 273 ARG ILE TYR GLU ALA TYR LEU LYS ASN PHE ASN MET ASN SEQRES 3 C 273 LYS VAL LYS ALA ARG VAL ILE LEU SER GLY LYS ALA SER SEQRES 4 C 273 ASN ASN PRO PRO PHE VAL ILE HIS ASP MET GLU THR LEU SEQRES 5 C 273 CYS MET ALA GLU LYS THR LEU VAL ALA LYS LEU VAL ALA SEQRES 6 C 273 ASN GLY ILE GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE SEQRES 7 C 273 HIS CYS CYS GLN CYS THR SER VAL GLU THR VAL THR GLU SEQRES 8 C 273 LEU THR GLU PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN SEQRES 9 C 273 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 C 273 VAL TYR GLU ALA ILE PHE ALA MET LEU SER SER VAL MET SEQRES 11 C 273 ASN LYS ASP GLY MET LEU VAL ALA TYR GLY ASN GLY PHE SEQRES 12 C 273 ILE THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 13 C 273 CYS ASP ILE MET GLU PRO LYS PHE ASP PHE ALA MET LYS SEQRES 14 C 273 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP ILE SER LEU SEQRES 15 C 273 PHE VAL ALA ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY SEQRES 16 C 273 LEU LEU ASN VAL GLY HIS ILE GLU LYS MET GLN GLU GLY SEQRES 17 C 273 ILE VAL HIS VAL LEU ARG LEU HIS LEU GLN SER ASN HIS SEQRES 18 C 273 PRO ASP ASP ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 C 273 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 C 273 LEU VAL GLN ILE ILE LYS LYS THR GLU SER ASP ALA ALA SEQRES 21 C 273 LEU HIS PRO LEU LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 D 15 LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN SEQRES 2 D 15 GLU GLY HET F5A A 501 36 HET F5A A 502 36 HET F5A C 501 36 HET F5A C 502 36 HETNAM F5A 2-[4-(4-CHLOROBENZENE-1-CARBONYL)PHENOXY]-2- HETNAM 2 F5A METHYLPROPANOIC ACID FORMUL 5 F5A 4(C17 H15 CL O4) FORMUL 9 HOH *200(H2 O) HELIX 1 AA1 THR A 200 PHE A 218 1 19 HELIX 2 AA2 ASN A 221 GLY A 231 1 11 HELIX 3 AA3 ASP A 243 LEU A 254 1 12 HELIX 4 AA4 LEU A 254 ASN A 261 1 8 HELIX 5 AA5 GLU A 267 ALA A 293 1 27 HELIX 6 AA6 ASP A 301 SER A 322 1 22 HELIX 7 AA7 ARG A 341 SER A 346 1 6 HELIX 8 AA8 PRO A 350 ILE A 354 5 5 HELIX 9 AA9 MET A 355 ALA A 367 1 13 HELIX 10 AB1 ASP A 371 CYS A 384 1 14 HELIX 11 AB2 ASN A 393 HIS A 416 1 24 HELIX 12 AB3 PHE A 421 GLU A 451 1 31 HELIX 13 AB4 HIS A 457 ARG A 465 1 9 HELIX 14 AB5 HIS B 687 GLU B 696 1 10 HELIX 15 AB6 THR C 200 PHE C 218 1 19 HELIX 16 AB7 ASN C 221 GLY C 231 1 11 HELIX 17 AB8 ASP C 243 LEU C 254 1 12 HELIX 18 AB9 LEU C 254 ASN C 261 1 8 HELIX 19 AC1 GLU C 267 ALA C 293 1 27 HELIX 20 AC2 ASP C 301 SER C 322 1 22 HELIX 21 AC3 ARG C 341 LEU C 347 1 7 HELIX 22 AC4 PRO C 350 ILE C 354 5 5 HELIX 23 AC5 MET C 355 ALA C 367 1 13 HELIX 24 AC6 ASP C 371 CYS C 384 1 14 HELIX 25 AC7 ASN C 393 HIS C 416 1 24 HELIX 26 AC8 PHE C 421 GLU C 451 1 31 HELIX 27 AC9 HIS C 457 ARG C 465 1 9 HELIX 28 AD1 HIS D 687 GLU D 696 1 10 SHEET 1 AA1 4 PHE A 239 ILE A 241 0 SHEET 2 AA1 4 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241 SHEET 3 AA1 4 GLY A 329 VAL A 332 -1 N MET A 330 O ILE A 339 SHEET 4 AA1 4 MET A 325 ASN A 326 -1 N ASN A 326 O GLY A 329 SHEET 1 AA2 4 PHE C 239 ILE C 241 0 SHEET 2 AA2 4 GLY C 337 THR C 340 1 O PHE C 338 N ILE C 241 SHEET 3 AA2 4 GLY C 329 VAL C 332 -1 N MET C 330 O ILE C 339 SHEET 4 AA2 4 MET C 325 ASN C 326 -1 N ASN C 326 O GLY C 329 CISPEP 1 LYS A 349 PRO A 350 0 -1.79 CISPEP 2 LYS C 349 PRO C 350 0 1.75 SITE 1 AC1 13 PHE A 273 CYS A 276 GLN A 277 SER A 280 SITE 2 AC1 13 TYR A 314 HIS A 440 VAL A 444 ILE A 447 SITE 3 AC1 13 LYS A 448 ALA A 454 ALA A 455 LEU A 456 SITE 4 AC1 13 TYR A 464 SITE 1 AC2 8 LEU A 247 LEU A 254 LYS A 257 CYS A 275 SITE 2 AC2 8 THR A 279 ALA A 333 TYR A 334 HOH A 680 SITE 1 AC3 12 PHE C 273 GLN C 277 SER C 280 TYR C 314 SITE 2 AC3 12 HIS C 440 VAL C 444 ILE C 447 LYS C 448 SITE 3 AC3 12 ALA C 454 ALA C 455 LEU C 456 TYR C 464 SITE 1 AC4 9 LEU C 247 LYS C 257 CYS C 275 THR C 279 SITE 2 AC4 9 GLU C 282 ALA C 333 TYR C 334 HOH C 613 SITE 3 AC4 9 HOH C 618 CRYST1 60.591 100.618 61.990 90.00 101.63 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016504 0.000000 0.003397 0.00000 SCALE2 0.000000 0.009939 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016470 0.00000